Thymoglobulin® Pharmacokinetics in Patients Undergoing Hematopoietic Stem Cell Transplantation

NCT05743400 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy

Interventions

DRUG: Thymoglobulin 25 milligrams (mg) Injection
BIOLOGICAL: blood test

Sponsor

Hospices Civils de Lyon